KENNETH BANNON: Open Payments
NPI 1821055047 · CARBONDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,386 in 132 payments from 19 companies in 2025. Trend: 2023 $1,785 · 2024 $1,890 · 2025 $3,386
Food & beverage: $3,386
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 25 | $693 |
| ABBVIE INC. | 24 | $515 |
| Janssen Biotech, Inc. | 13 | $417 |
| Madrigal Pharmaceuticals | 7 | $362 |
| Regeneron Healthcare Solutions, Inc. | 9 | $205 |
| Ardelyx, Inc. | 10 | $196 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $194 |
| Janssen Scientific Affairs, LLC | 2 | $188 |
| PFIZER INC. | 12 | $145 |
| GENZYME CORPORATION | 5 | $127 |
Products named: Sucraid, TREMFYA, REZDIFFRA, DUPIXENT, LINZESS, IBSRELA, XIFAXAN, MAVYRET.
Industry payments across PA — which companies pay providers there.
